SCHEMBL4669255

SCHEMBL4669255

Cc1cc(/C=C/C(=O)NCCc2c(C)[nH]c3c(F)ccc(C)c23)cnc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GSK3B P49841 8/20 0.35
HDAC1 Q13547 3/20 0.35
PLK4 O00444 1/20 0.35
AURKA O14965 1/20 0.35
JAK2 O60674 1/20 0.35
ROCK2 O75116 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35
ABL1 P00519 1/20 0.35
EGFR P00533 1/20 0.35
ERBB2 P04626 1/20 0.35
NTRK1 P04629 1/20 0.35
INSR P06213 1/20 0.35
LCK P06239 1/20 0.35
FYN P06241 1/20 0.35
CSF1R P07333 1/20 0.35
LYN P07948 1/20 0.35
MET P08581 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4754383 1.00 MEN1 (0.41) MEN1KMT2AGSK3BHDAC1PLK4
SCHEMBL4669474 0.90 MEN1 (0.42) MEN1KMT2AGSK3BHDAC1HDAC4
SCHEMBL4754759 0.90 MEN1 (0.42) MEN1KMT2AGSK3BHDAC1HDAC4
SCHEMBL13982589 0.86 MEN1 (0.43) MEN1KMT2AHDAC1HDAC4LMNA
SCHEMBL4669466 0.85 MEN1 (0.39) MEN1KMT2AGSK3BHDAC1HDAC4
SCHEMBL4669463 0.85 MEN1 (0.39) MEN1KMT2AGSK3BHDAC1HDAC4
SCHEMBL4755393 0.85 MEN1 (0.43) MEN1KMT2AHDAC1HDAC4MEF2D
SCHEMBL4668517 0.85 MEN1 (0.43) MEN1KMT2AHDAC1HDAC4MEF2D
SCHEMBL4019849 0.85 MEN1 (0.44) MEN1KMT2AHDAC1HDAC4MEF2D
SCHEMBL4015068 0.85 MEN1 (0.44) MEN1KMT2AHDAC1HDAC4MEF2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO claimed
EP-2003118-A1 Cinnamic acid derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP claimed
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO disclosed
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO disclosed
EP-2003118-A1 Cinnamic acid derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP disclosed